Augtyro
repotrectinib
- Strength
- 40 mg/1
- Form
- Capsule
- Class
- Kinase Inhibitor
E.R. Squibb & Sons, L.L.C.
Not stocked by us — reference only
repotrectinib
Listed by E.R. Squibb & Sons, L.L.C.
| Dosage form | Capsule |
|---|---|
| Route | Oral |
| Drug class | Kinase Inhibitor |
| Approval route | NDA — original brand approval |
| NDC code | 0003-4160 |
| FDA application | NDA218213 |
| RxNorm concept | 2670649 |
| Package sizes listed | 2 |
| Marketed since | November 2024 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
repotrectinib
E.R. Squibb & Sons, L.L.C.
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.